Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Dr Reddy’s Opens Manufacturing Facility For Pharma Grade mPEG Alcohols In Mexico

PBR Staff Writer Published 18 March 2010

The Custom Pharmaceutical Services (CPS) business of Dr Reddy’s Laboratories has opened commercial scale manufacturing facility for pharma grade mPEG alcohols at its Cuernavaca facility in Mexico.

mPEG Alcohols are the key raw materials for activated mPEG alcohols, which are extensively used for pegylation with biologic drugs and increasingly for peptides and small molecule pharmaceuticals. Dr Reddy’s has officially announced PEGtech as its product brand for its extensive range of activated mPEGs.

Dr Reddy’s, said that the new assets in Mexico represent a significant investment in a dedicated facility operated to c-GMP standards which is capable of producing a wide range of molecular weight mPEGs and has a multi tonne annual capacity.

The mPEG alcohol manufactured in Mexico is expected to be supplied to Dr Reddy’s c-GMP facility in Mirfield, UK, where commercial scale activation is carried out. PEGtech branding has been used to bring together a broad product range comprising a variety of activating groups and molecular weights (5-60 kDa), which are now fully supported by backward integration to the key starting materials.

Satish Reddy, MD and COO at Dr Reddy’s said: "Our investment in the world class mPEG alcohol facility in Mexico underlines our commitment to the growing market for Activated mPEGs. By introducing the PEGtech brand, our customers can be assured of the same high quality standards and customer service as they develop their PEGylated biologic drugs or small molecules from the laboratory right through to commercial applications."